Full trial results released for new progressive MS treatment ocrelizumab
February 1, 2017The full clinical trial results have been published for ocrelizumab (Ocrevus®), a new treatment option for primary progressive MS and relapsing MS. To read more, click on the below link:
Full trial results released for new progressive MS treatment ocrelizumab
Article courtesy of MS Research Australia www.msra.org.au